SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000863894-24-000008
Filing Date
2024-04-01
Accepted
2024-04-01 15:42:44
Documents
82
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q veru-20231231x10q.htm   iXBRL 10-Q 2414055
2 EX-31.1 veru-20231231xex31_1.htm EX-31.1 15658
3 EX-31.2 veru-20231231xex31_2.htm EX-31.2 15883
4 EX-32.1 veru-20231231xex32_1.htm EX-32.1 11664
  Complete submission text file 0000863894-24-000008.txt   10185103

Data Files

Seq Description Document Type Size
5 EX-101.SCH veru-20231231.xsd EX-101.SCH 60350
6 EX-101.CAL veru-20231231_cal.xml EX-101.CAL 57528
7 EX-101.DEF veru-20231231_def.xml EX-101.DEF 220065
8 EX-101.LAB veru-20231231_lab.xml EX-101.LAB 421457
9 EX-101.PRE veru-20231231_pre.xml EX-101.PRE 392900
86 EXTRACTED XBRL INSTANCE DOCUMENT veru-20231231x10q_htm.xml XML 2181303
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 24808837
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)